2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline

C181H112F10N24O4 — CID 160528858

IUPAC2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline
SMILESCOc1cc(OC)nc(-c2ccc3c(c2)-c2cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc2C3(F)F)n1.COc1nc(OC)nc(-c2ccc3c(c2)-c2cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc2C3(F)F)n1.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3cccc4cccnc34)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3cccc4nccnc34)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3nc4ccccc4c4ccccc34)ccc21
InChIInChI=1S/C41H24F2N4.C37H22F2N4.C36H21F2N5.C34H23F2N5O2.C33H22F2N6O2/c42-41(43)34-21-19-27(37-31-17-8-7-15-29(31)30-16-9-10-18-36(30)44-37)23-32(34)33-24-28(20-22-35(33)41)40-46-38(25-11-3-1-4-12-25)45-39(47-40)26-13-5-2-6-14-26;38-37(39)31-18-16-26(28-15-7-13-23-14-8-20-40-33(23)28)21-29(31)30-22-27(17-19-32(30)37)36-42-34(24-9-3-1-4-10-24)41-35(43-36)25-11-5-2-6-12-25;37-36(38)29-16-14-24(26-12-7-13-31-32(26)40-19-18-39-31)20-27(29)28-21-25(15-17-30(28)36)35-42-33(22-8-3-1-4-9-22)41-34(43-35)23-10-5-2-6-11-23;1-42-28-19-29(43-2)38-32(37-28)22-13-15-26-24(17-22)25-18-23(14-16-27(25)34(26,35)36)33-40-30(20-9-5-3-6-10-20)39-31(41-33)21-11-7-4-8-12-21;1-42-31-39-30(40-32(41-31)43-2)22-14-16-26-24(18-22)23-17-21(13-15-25(23)33(26,34)35)29-37-27(19-9-5-3-6-10-19)36-28(38-29)20-11-7-4-8-12-20/h1-24H;1-22H;1-21H;3-19H,1-2H3;3-18H,1-2H3
InChIKeyQVGNXKICBIYCIQ-UHFFFAOYSA-N
MW2877.03 g/mol
LogP42.50
Rot. Bonds24

About 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline

2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline (PubChem CID 160528858) has the molecular formula C181H112F10N24O4 and a molecular weight of 2877.03 g/mol. Its IUPAC name is 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline.

Molecular Properties

Compound Name2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline
PubChem CID160528858
Molecular FormulaC181H112F10N24O4
Molecular Weight2877.03 g/mol
Exact Mass2874.91
IUPAC Name2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline
SMILESCOc1cc(OC)nc(-c2ccc3c(c2)-c2cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc2C3(F)F)n1.COc1nc(OC)nc(-c2ccc3c(c2)-c2cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc2C3(F)F)n1.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3cccc4cccnc34)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3cccc4nccnc34)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3nc4ccccc4c4ccccc34)ccc21
InChIInChI=1S/C41H24F2N4.C37H22F2N4.C36H21F2N5.C34H23F2N5O2.C33H22F2N6O2/c42-41(43)34-21-19-27(37-31-17-8-7-15-29(31)30-16-9-10-18-36(30)44-37)23-32(34)33-24-28(20-22-35(33)41)40-46-38(25-11-3-1-4-12-25)45-39(47-40)26-13-5-2-6-14-26;38-37(39)31-18-16-26(28-15-7-13-23-14-8-20-40-33(23)28)21-29(31)30-22-27(17-19-32(30)37)36-42-34(24-9-3-1-4-10-24)41-35(43-36)25-11-5-2-6-12-25;37-36(38)29-16-14-24(26-12-7-13-31-32(26)40-19-18-39-31)20-27(29)28-21-25(15-17-30(28)36)35-42-33(22-8-3-1-4-9-22)41-34(43-35)23-10-5-2-6-11-23;1-42-28-19-29(43-2)38-32(37-28)22-13-15-26-24(17-22)25-18-23(14-16-27(25)34(26,35)36)33-40-30(20-9-5-3-6-10-20)39-31(41-33)21-11-7-4-8-12-21;1-42-31-39-30(40-32(41-31)43-2)22-14-16-26-24(18-22)23-17-21(13-15-25(23)33(26,34)35)29-37-27(19-9-5-3-6-10-19)36-28(38-29)20-11-7-4-8-12-20/h1-24H;1-22H;1-21H;3-19H,1-2H3;3-18H,1-2H3
InChIKeyQVGNXKICBIYCIQ-UHFFFAOYSA-N
XLogP42.50
TPSA346.28 Ų
H-Bond Donors
H-Bond Acceptors28
Rotatable Bonds24
Heavy Atoms219
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002877.03
LogP ≤ 542.50
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline?
The IUPAC name of 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline (CID 160528858) is 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline.
What is the SMILES notation for 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline?
The canonical SMILES for 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline is COc1cc(OC)nc(-c2ccc3c(c2)-c2cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc2C3(F)F)n1.COc1nc(OC)nc(-c2ccc3c(c2)-c2cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc2C3(F)F)n1.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3cccc4cccnc34)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3cccc4nccnc34)ccc21.FC1(F)c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2-c2cc(-c3nc4ccccc4c4ccccc34)ccc21.
What is the InChIKey of 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline?
The InChIKey is QVGNXKICBIYCIQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H24F2N4.C37H22F2N4.C36H21F2N5.C34H23F2N5O2.C33H22F2N6O2/c42-41(43)34-21-19-27(37-31-17-8-7-15-29(31)30-16-9-10-18-36(30)44-37)23-32(34)33-24-28(20-22-35(33)41)40-46-38(25-11-3-1-4-12-25)45-39(47-40)26-13-5-2-6-14-26;38-37(39)31-18-16-26(28-15-7-13-23-14-8-20-40-33(23)28)21-29(31)30-22-27(17-19-32(30)37)36-42-34(24-9-3-1-4-10-24)41-35(43-36)25-11-5-2-6-12-25;37-36(38)29-16-14-24(26-12-7-13-31-32(26)40-19-18-39-31)20-27(29)28-21-25(15-17-30(28)36)35-42-33(22-8-3-1-4-9-22)41-34(43-35)23-10-5-2-6-11-23;1-42-28-19-29(43-2)38-32(37-28)22-13-15-26-24(17-22)25-18-23(14-16-27(25)34(26,35)36)33-40-30(20-9-5-3-6-10-20)39-31(41-33)21-11-7-4-8-12-21;1-42-31-39-30(40-32(41-31)43-2)22-14-16-26-24(18-22)23-17-21(13-15-25(23)33(26,34)35)29-37-27(19-9-5-3-6-10-19)36-28(38-29)20-11-7-4-8-12-20/h1-24H;1-22H;1-21H;3-19H,1-2H3;3-18H,1-2H3.
What are the key properties of 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline?
2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline has a molecular weight of 2877.03 g/mol, XLogP of 42.50, 24 rotatable bonds, 0 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-(4,6-dimethoxypyrimidin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;2-[6-(4,6-dimethoxy-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]-4,6-diphenyl-1,3,5-triazine;6-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]phenanthridine;8-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoline;5-[6-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-difluorofluoren-3-yl]quinoxaline is sourced from PubChem (CID 160528858), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).